Recognition of pathogens and altered self must be efficient and highly specific to orchestrate appropriate responses while limiting excessive inflammation and autoimmune reaction to normal self. AIM2 is a member of innate immune sensors that detects the presence of DNA, arguably the most conserved molecules in living organisms.
Summary
Recognition of pathogens and altered self must be efficient and highly specific to orchestrate appropriate responses while limiting excessive inflammation and autoimmune reaction to normal self. AIM2 is a member of innate immune sensors that detects the presence of DNA, arguably the most conserved molecules in living organisms.
However, AIM2 achieves specificity by detecting altered or mislocalized DNA molecules. It can detect damaged DNA, and the aberrant presence of DNA within the cytosolic compartment such as genomic DNA released into the cytosol upon loss of nuclear envelope integrity. AIM2 is also a key sensor of pathogens that detects the presence of foreign DNA accumulating in the cytosol during the life cycle of intracellular pathogens including viruses, bacteria, and parasites. AIM2 activation initiates the assembly of the inflammasome, an innate immune complex that leads to the activation of inflammatory caspases. This triggers the maturation and secretion of the cytokines IL-1β and IL-18. It can also initiate pyroptosis, a proinflammatory form of cell death. The AIM2 inflammasome contributes to physiological responses and diseases. It is a key player in host defenses, but its deregulation can contribute immune-linked diseases, such as autoinflammatory and autoimmune pathologies. Moreover, AIM2 may play a role in cancer development. Recent studies have shown that the detection of self-DNA species by AIM2 is an important factor that contributes to diseases associated with perturbation of cellular homeostasis. Thus, in addition of being a sensor of pathogen associated molecular patterns (PAMPs), the AIM2 inflammasome is emerging as a key guardian of cellular integrity.
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| INTRODUCTION
Pathogens as well as signals triggered by cellular perturbations engage innate immune programs. These responses use a set of germlineencoded pattern recognition receptors (PRRs) to limit the spreading of pathogens and restore tissue integrity and function. Each PRR functions by recognizing specific molecular signatures. If these signals originate from the microbial world they are referred to as pathogen-associated molecular patterns (PAMPs) or microbe-associated molecular patterns (MAMPs). If the PRRs detect self-signatures, these signals are termed danger associated molecular patterns (DAMPs) or stress signals also known as alarmins. 1 These stress signals can be generated by the loss of cellular integrity. The term homeostasis-altering molecular processes (HAMPs) has been proposed to define pro-inflammatory alterations of cellular homeostasis. 2 receptors (ALRs). Although these different families differ in their overall structure, they converge on similar signal transduction cascades that eventually trigger the activation of pro-inflammatory transcription factors such as type I interferon and NF-κB. A group of NLRs and ALRs can form inflammasomes. These protein complexes form signaling platforms that harbor a proteolytic activity at their core. This enzymatic activity leads to the activation of pyroptosis-mediated cell death and/ or the release of active IL-1β and IL-18. These two cytokines engage the transmembrane receptors IL-1R and IL-18R to promote inflammation via the activation of NF-κB transcriptional programs through the activation of MyD88 a key signaling adaptor in innate immunity. 3 The proinflammatory transcription factors such as type I IFN and NF-κB pathway regulate cytokines and chemokines production thereby promoting leukocyte recruitment. These factors also regulate feedback controls of inflammation orchestrating the magnitude and duration of immune responses. Deregulation of these signals can contribute to diseases by promoting uncontrolled inflammation. PRRs activation are often involved in the initial steps eliciting deregulated inflammation. Defining the mechanisms by which PRRs are activated and regulated is therefore a key step in understanding how deregulated inflammation is initiated in several conditions and diseases.
Here, we will review the biology of AIM2, an inflammasomeforming PRR. We will discuss its ability to detect both self and non-self DNA and how this pathway contributes to diseases.
| AIMDEFINES A NEW CLASS OF INNATE IMMUNE SENSORS

| AIM2 structural organization
AIM2 and the ALRs are structurally defined by two main domains; the HIN domain and the pyrin domain (PYD). The HIN domain is present in one copy in AIM2, but some ALRs such as IFI16 harbors two HIN domains at the C-terminus. This domain has structural similarities to the oligonucleotide/oligosaccharide binding (OB)-folds. 4 The OB fold consists of five or six-stranded β-barrel formed by 70-80 amino acid residues. The strands are connected by loops of varying length that form the ligand- The PYD domain that characterizes the N-terminus of the ALRs is a member of the death fold structures formed by six coiled alpha helices arranged in a "Greek-key" fold. 7, 8 This fold is commonly found in proteins involved in apoptosis or inflammation and participates in protein-protein interactions leading to the formation of large signaling complexes. Death folds commonly bind to other death-fold containing domains of the same type through homotypic interactions. Therefore, PYD domain proteins interact with other PYD domain proteins via highly specific PYD-PYD interactions. Upon activation, AIM2 binds and recruits the adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) via PYD-PYD interactions. [9] [10] [11] This interaction contributes to the initial steps of inflammasome assembly.
| The ALRs family has undergone recent and rapid evolution
ALRs are exclusively present in placental mammals and marsupial genomes. 12 Phylogenetic analyses have shown that mammalian ALRs have evolved considerably, leading to diversification of the repertoire. 13 Except for AIM2 that is possibly the most conserved ALR, no evident orthology is detected between the thirteen predicted mouse and the four human ALRs. Other mammals such as cow have only one predicted ALR in the genome. 12 Such a remarkable diversity among relatively close species has been observed for genes involved in innate immunity. 14 This was noted for the NLRP family, another group of PRR forming inflammasomes. 15 It is likely that such diversity may reflect selective pressure placed on these genes by pathogens. 16 While AIM2
appears to be able to recognize DNA molecules independently of the sequence, it is possible that other ALRs may detect specific sequences or modifications that would identify the pathogenic DNA encountered.
This hypothesis could explain the selection pressure observed for ALRs family member and the relative conservation of AIM2. Analysis of AIM2 genome suggested that AIM2 expression is deficient in the genome of some mammals such as cow, sheep, dolphin, pig, cat, and dog.
This may indicate that through amplification and duplication processes other ALRs may have fulfilled AIM2 function in these mammals.
Interestingly, analysis of over ten bat genomes revealed that all bats had lost the entire ALRs repertoire while other NLR innate immune sensors such as NLRP3 were conserved. 17 The evolutionary events that specifically removed the ALRs genes from bats genomes are still unclear. Bats are the only mammals capable of flight. This process is very demanding on the metabolic machinery and may cause the accumulation of harmful metabolic byproducts that can affect cellular homeostasis and integrity.
Inflammatory and repair pathways could be induced as a response to the release of these stress signals. Thus, it has been suggested that the loss of ALRs could be part of an adaptation during the evolution of flight.
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While this hypothesis is of interest, it also possible that the loss of ALRs in bats may reveal an evolutionary arms race that occurred between pathogens and this host. Bats are well-known reservoir of numerous pathogens including DNA viruses. It is possible that the loss of ALRs in these organisms is the result of a co-evolution between bat innate immune sensors and a pathogen. While the mechanisms that triggered the loss of ALRs in bats are still unclear, it is likely that the loss of ALRs facilitates evasion of host immune responses by pathogens, explaining how these organisms became suitable hosts of many viruses and other disease agents.
| AIM2 is induced by type I interferon
Using subtractive cDNA selection, AIM2 (that refers to Absent In Melanoma 2) was identified as a gene that was differentially expressed in a model of melanoma. 18 While the function of this protein was unknown at the time, hints on its function emerged from studies that characterized its localization and pattern of expression. AIM2 is localized mostly within the cytoplasm of cells, suggesting that it was likely not involved in directly regulating transcriptional processes. 19 Expression studies showed that, at basal, AIM2 expression is mostly detected in the spleen, in small intestine, and in peripheral blood. 12 However, AIM2 expression can rapidly be induced. In fact, most ALRs expression is upregulated upon treatment that promote type I IFN.
This observation defined early research on this family and linked ALRs proteins with inflammation and immunity. [20] [21] [22] Studies in mice confirmed that most ALRs are inducible by type I IFN signaling. 13 Interferons are important mediators of host defenses against invading bacteria and viruses and can also contribute to autoinflammation. 30 At the initiation stages of apoptosis, mitochondrial cytochrome c is released into the cytosol. Then, cytochrome c binds apoptotic protease activating factor-1 (Apaf-1), triggering a conformational change that results in its oligomerization and recruitment of caspase-9. The resulting apoptosome facilitates the autocatalytic cleavage of the pro-caspase-9 that remains active and associated with the apoptosome. 31 Studies on the apoptosome inspired the experiments that lead to the initial discovery of the inflammasome. The inflammasome was first detected in a cellfree assay that was designed to study the apoptosome complex. 28 The term inflammasome was coined to acknowledge the apparent similarity of the complex with the apoptosome and to indicate that its main function is the activation of inflammatory caspases such as caspase-1. In contrast to the apoptosome that is a well-conserved and unique complex, inflammasomes can be assembled by several initiator PRRs that can detect different stimuli. However, most classical inflammasomes share common mechanisms of activation that were initially described in the context of NLRP3 inflammasome activation.
32,33
The NLRP3 inflammasome is formed by the recruitment of the adaptor ASC through PYD-PYD interactions and subsequent recruitment of caspase-1 via the caspase CARD and the CARD of ASC. As a result of the initial ASC oligomerization within the inflammasome, ASC can further auto-assemble into large filament structures. This process is referred to as "prion-like" polymerization. It dramatically amplifies the inflammasome assembly by virtually engaging all ASC molecules into one active molecular structure. 34 This amplification was described for several signaling pathways that use the death fold (such as PYD and CARD) as a recruitment and activation domain. Most of these pathways are involved in innate immunity and may have evolved to enable a robust and rapid response to an insult. 35 Prionization of the signal has been observed for all ASC-containing inflammasome tested so far including the AIM2 inflammasome. 36 Within the AIM2 inflammasome, the PYD of AIM2 drives both filament formation and may facilitate ligand binding. 37 The AIM2
PYD oligomers orchestrate the filamentous structure of the downstream ASC filaments and subsequent AIM2 inflammasome signaling ( Figure 1 ). These filaments form a multitude of caspase-1 activation sites, thereby amplifying inflammasome signaling. 
| Inflammasomes mediated IL-1β and IL-18 production
In contrast with apoptotic caspases that have multiple substrates described so far, inflammatory caspases have only a few bona fide substrates that have been characterized. Inflammatory caspases are termed "inflammatory" because the main caspase-1 substrates identified to date are proIL-1β and proIL-18, two structurally related cytokines that contribute to inflammation. IL-1β is a pleiotropic cytokine that acts on multiple cell types to drive inflammatory responses. 39 At the systemic level, IL-1β elicits a fever response by acting directly on the hypothalamic temperature regulation centre. 40 41 This similarity clearly indicates that the inflammasome-IL-1β/IL-18 system and the TLRs engage analogous response at the molecular level and suggest these innate pathways are variations that originate from a common ancestor pathway.
| Inflammasomes mediated pyroptosis
Another important target of inflammasome proteolytic activity leads to the activation of a pro-inflammatory type of cell death termed pyroptosis. 42, 43 Pyroptosis was first observed in macrophages infected with intracellular bacteria. 44, 45 In infected macrophages, caspase-1 deficiency impaired pyroptosis. In addition to caspase-1, other pro- caspase-1 independent cell death, by a process that resemble apoptosis. 47 It is therefore likely that in the context of caspase-1 inhibition;
inflammasome platform can engage alternative routes to trigger cell death, similarly to apoptosis processes that can elicit necroptosis in the absence of caspases. 48, 49 Recently, a family of proteins named Gasdermins have emerged as key mediators of inflammatory caspases-mediated cells death.
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Caspase-1 or caspase-11 have been shown to cleave Gasdermin D (GSDMD). This releases the N-terminal portion of the Gasdermin that then polymerizes at the plasma membrane forming cytotoxic pores.
These pores disrupt cellular integrity and result in cell death with typical feature of pyroptosis ( Figure 2 ).
| AIM2 DETECTION OF DNA
Transfection of host, bacterial and viral DNA, beside its effects on the transcriptional activation of type-I IFN, has been shown to initiate a cascade leading to the proteolytic maturation of IL-1β. These DNA molecules relied on an ASC-dependent but NLRP3-independent inflammasome. 53 The use of an orthogonal proteomic-genomic screen in mouse F I G U R E 1 Activation of the AIM2 inflammasome. AIM2 is composed an N-terminal pyrin domain (PYD) and a C-terminal HIN domain. Both domains interact to keep the molecule auto-inhibited. Upon binding of dsDNA auto-inhibition is released leading to AIM2 oligomerization and the recruitment of the adaptor ASC via PYD-PYD interactions. ASC recruitment leads to polymerization of the ASC protein leading to the formation of fibrilar super-structures. Caspase-1 is recruited to the complex via CARD-CARD interactions. Its oligomerization on the complex promotes its activity leading to the proteolytic maturation of caspase-1 substrates such as the IL-1β precursor (pro-IL-1β) that is processed into the biologically active IL-1β cell lines, identified AIM2 as the main cytoplasmic DNA sensor promoting inflammasome assembly. A proteomic screen for DNA-binding proteins that interacted with IFN-β-stimulating dsDNA was coupled to a genomic screen for IFN-β regulated genes. The results of these screens were crossed and several ALR proteins were identified as candidates of interest. Among them, AIM2 was found to trigger an inflammasome while coexpressed with ASC, caspase-1 and IL-1β. 9 Other studies showed that the AIM2 PYD domain was necessary to interact with ASC to nucleate an inflammasome. 10, 11 These studies demonstrated that AIM2 is the cytosolic sensor for dsDNA that, upon engagement, promotes the activation of caspase-1 in mouse BMDMs. In contrast, the decoy ALR protein p202 was found to repress dsDNA activation of caspase-1. 54 AIM2 cytosolic subcellular localization and its ability to detect cytosolic DNA make of this protein a bona fide cytosolic innate immune sensor.
| DNA sensors
The ability of the immune system to respond to DNA was first discovered with the study of the endosomal toll-like receptor 9 (TLR9).
TLR9 binds CpG DNA from bacteria and triggers innate immune responses via the MyD88 adaptor. 55 The DEAD/H-box helicases DHX9 and DHX36 were also found to be MyD88-dependent DNA sensors that activate NF-κB and IRF7 in plasmacytoid dendritic cells. 56 DNA-dependent protein kinase (DNA-PK), a protein complex, was found to detect cytosolic DNA via the Ku70 subunit leading to the activation of type III IFNs. 57 Several DNA sensors have been described to elicit a strong type I IFN response signal through the activation of the adaptor protein STING. 58 STING is a master regulator of type I IFN innate immunity triggered by cytosolic DNA. 59 It centralizes the signal from the DNA sensors cGAS, 60, 61 DDX41, 62 DNA-PK, 63 MRE11, 64 DAI/ZBP1 65, 66 and possibly the ALR protein IFI16 and its mouse ortholog p204. 67 These pathways trigger the STING-TBK1-IRF3/7 axis and subsequent transcription of type I IFNs. 58 Compared to other DNA sensors AIM2 is specialized in inflammasome assembly rather than promoting type I IFN responses.
| AIM2 directly binds DNA molecules
Biochemical studies indicated that AIM2 binds DNA directly and that the HIN domain was sufficient for this interaction. 11 Consistently, mutations within the HIN domain impaired AIM2 ability to bind immunostimulatory dsDNA immobilized on resin. 9 ALRs were described to bind dsDNA of virtually any origin including microbial, host or synthetic molecules that vary in sequence and GC content. [9] [10] [11] 54, 67 The lack of apparent specificity of the HIN-DNA interactions is sup- 
| AIM2 detects DNA from pathogens
During infections with intracellular pathogens, microbial DNA can be released in the cytosol. AIM2 function as a DNA sensor has been extensively described in the context of several microbes and pathogens, 71 further highlighting the role of this protein in innate immunity.
| AIM2 detects bacterial DNA
Francisella tularensis [72] [73] [74] and Lysteria monocytogenes 73, 75 were the first live bacteria identified to engage the AIM2 inflammasome. In particu- 
| AIM2 detection of viruses
Given its abilities to recognize non-specifically dsDNA structures, one may picture AIM2 to be a broad sensor of DNA viruses. 
| AIM2 detects endogenous self-DNA upon disruption of nuclear envelope integrity
The nuclear envelope (NE) defines a cellular compartment that isolates the nucleus and its content from the cytoplasm. The NE inner and outer membranes are highly dynamic structures riddled with proteins that regulate their functions. 82 The nuclear lamina is a meshwork of proteins lining the inner nuclear membrane, crucial to NE integrity, transmission of mechanical forces, chromatin organization, and gene transcription. 83 
| AIM2 detects DNA damage within the nucleus
Besides its well-described ability to detect dsDNA within the cytosol, AIM2 has been recently proposed to detect DNA damage directly within the nucleus. 94 In a mouse model of subtotal body exposure to ionizing radiation with gastrointestinal toxicity, inflammasomedeficient mice were found to be more resistant to irradiation. AIM2 was identified as the only inflammasome sensor responsible for resistance to irradiation-induced intestinal toxicity in this model. Irradiation toxicity was mediated by pyroptosis of epithelial intestinal cells.
Notably, drugs such as doxorubicin and etoposide that trigger DNA double-strand breaks (DSB) also promoted AIM2-mediated cell death.
In contrast UV irradiation, that mediates single-strand breaks, did not rely on AIM2 to promote cytotoxicity. Interestingly AIM2 colocalized with γ-H2Ax at sites of DSB in irradiated BMDM. Moreover, ASC specks were also identified within the nucleus upon DNA damage, indicating that the AIM2 inflammasome can assemble and function within nuclei. Whether nuclear inflammasomes have different proteolytic substrates than cytosolic inflammasome is a possibility that needs to be investigated. While IL-1β localization within the nucleus was detected before, 95 the pyroptosis-mediating factor Gasdermin D was reported to be exclusively cytosolic. 96 It is possible that Gasdermin D localizes in the nucleus of epithelial cells undergoing DNA damage, alternatively AIM2 could use a different pathway to promote pyroptotic cell death upon DNA damage.
| AIM2 detects released self-DNA secreted by exosomes
Besides sensing cell intrinsic dsDNA, AIM2 in macrophages and dendritic cells has recently been proposed to sense self-DNA delivered by exosomes produced by intestinal epithelial cells exposed to chemotherapeutic agents. 97 In colon cancer patients treated with the cytotoxic chemotherapeutic agent CPT-11 (Irinotecan), the severity of side-effects such as diarrhea correlated with serum levels of dsDNA. expression was reported to be required in both hematopoietic and non-hematopoeitic lineages in order to mount a full response to DNA vaccine. 98 The mechanisms and cell types involved remain to be determined. AIM2 deficiency decreased type I IFN production in AIM2-deficient mice treated with DNA vaccine. This observation is puzzling and needs to be further investigated. The cGAS/STING pathway has been described to significantly contribute to DNA vaccine-mediated immunogenicity. 59, 99 However, AIM2 inflammasome activation has been reported to antagonize the STING pathway. 100 This antagonism relies on cleavage of cGAS by caspase-1. 101 It is therefore possible that the regulation of type I interferon and the activation of the AIM2 inflammasome occurs at a different time or in a different cell type in the course of DNA vaccination.
| AIM2 detects DNA vaccines
Because of its ability to detect DNA vaccines, increased AIM2 expression was considered as an attractive strategy to boost DNA vaccination protocols. Three recent studies showed that immunization of mice against coxsackie virus B3 (CVB3) using AIM2 as a mucosal adjuvant had beneficial effects. Indeed compared to mice immunized with CVB3-specific chitosan-pVP1, co-immunization of mice with CVB3-chitosan-pVP1 and chitosan-pAIM2 conferred better resistance to CVB3-induced myocarditits, increased secretory IgA, 102 increased CVB3-specific T cells responses 103 and increased counts of CD8 + memory T cells. 104 
| REGULATION OF AIM2
Inappropriate or chronic activation of inflammasomes can lead to diseases displaying features of autoinflammation. 105 Regulation of the engagement, the intensity and the duration of the response is therefore critical to optimize the reaction while minimizing possible side effects of inflammation. While complete understanding of the overall circuitry of inflammasomes regulation is still missing, a few mechanisms impacting AIM2 activity have been described. 108 indicating that specific sequence may interfere with ALRs activations. It is possible that these sequences compete for AIM2 binding thereby blocking the recognition of pro-inflammatory DNA sequences.
| Regulation of ligand availability
Whether similar sequences from endogenous sources or from pathogens can efficiently regulate AIM2, is an interesting hypothesis that has not been demonstrated yet. However, the physiological relevance of these putative regulators is still uncharacterized.
| Regulation AIM2 by encoded decoy proteins
Other decoy proteins in the pathway have been described within the ALR family. In mice, the ALR p202 lacks the PYD domain and has been shown to inhibit AIM2 activation. 54 Mouse p202 harbors two HIN domains, one has been shown to interact with dsDNA while the other one has affinity for AIM2 HIN domain. 113 It is possible that p202 
| Other regulators of AIM2
Beyond regulators that impact ligand accessibility and impair the assembly of inflammasomes, AIM2 protein levels can be directly regulated. The tripartite motif 11 (TRIM11) was reported to be a key negative regulator of the AIM2 inflammasome. Upon activation, TRIM11 interacts with AIM2 leading to the recruitment of the autophagic cargo receptor p62. The recruitment of this machinery to AIM2 leads to AIM2 degradation via selective autophagy. 115 These findings demonstrate that post-translational modifications contribute to inflammasomes regulation and may be key at regulating the intensity and duration of the inflammatory responses. Remarkably, F. novicida developed a clustered, regularly interspaced, short palindromic repeats-CRISPR associated-Cas (CRISPR-Cas) system strengthening bacterial envelope and conferring resistance to host sensors AIM2 and TLR2. 123 Recently, components of the type VI secretion system (T6SS) PdpC and PdpD encoded on the Francisella pathogenicity island and the chaperone ClpB were shown to be essential for phagosome escape of F. tularensis. 124 Phagosomal rupture and AIM2 inflammasome activation depended on T6SS disassembly, which is regulated by ClpB. Strains lacking pdpC and pdpD, normally released by T6SS, were also unable to escape phagosome and activate AIM2 but their exact function is still not characterized. could also be detected. 78 Human primary keratinocytes released IL-1β and IL-18 when transfected with HPV16 DNA and silencing of AIM2 greatly reduced this release. 78 In an ex vivo human APC model, immune-complexed adenovirus was reported to destabilize endosomal membrane via the release of protein VI during capsid disassembly promoting the release of viral DNA in the cytoplasm of the APC.
Viral DNA then activated AIM2 inflammasome triggering caspase-1 cleavage, IL-1β maturation and GSDMD processing. 125 This process has not been studied in vivo so far and whether it benefits to host or pathogen needs to be investigated. AIM2 was also reported to promote inflammation-mediated renal damage in patients with Hepatitis should play a role in systemic inflammation during malaria infection in humans. However, its exact role on the pathophysiology of malaria is still to be characterized in vivo.
The AIM2 inflammasome is also involved in the pathogenesis of leishmaniasis in patients infected with Leishmania (V.) braziliensis.
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AIM2 and CASP1 mRNA have been found more expressed in tissue from lesions of mucosal leishamaniasis compared to lesions from the less severe cutaneous leishamaniasis. AIM2 expression and number of IL-1β positive cells were also higher in lesions of patients poorly responding to therapy. 132 How host-or protozoan-derived DNA activates AIM2 inflammasome in tegumentary leishmania lesions still remains unclear.
Perturbation in the AIM2 pathway has been reported to deregulate the commensal microbiota, indicating that the AIM2 inflammasome is a central regulator of intestinal homeostasis. [133] [134] [135] It may contribute to maintain the production of epithelial antimicrobial host defense, 136 and its deregulation may contribute to disease progression in the mucosa of patients with active inflammatory bowel disease. 137 
| Autoinflammation
The concept of autoinflammatory diseases was coined to distinguish a set of inflammatory autosomal-dominant diseases from self-directed autoimmune diseases. 138 Immunotherapies aimed at reducing the amount of circulating IL-1β or at decreasing its ability to bind to the IL-1R complex have been proven to be very efficient in these patients at decreasing systemic inflammatory symptoms such as fever and skin rashes. 
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Abundant cytosolic DNA was also observed in keratinocytes in psoriatic lesions. In this disease, cytosolic DNA, behave like a "diseaseassociated molecular pattern" that can elicit AIM2 inflammasome leading to IL-1β maturation and the autoinflammation signs observed in psoriasis patients. 144 To date, AIM2 had not been linked to inherited autoinflammatory diseases and no gain-of function mutations have been identified within AIM2 gene. This is possibly due to the fact that AIM2 oligomerization may rely on DNA binding, which may promote the assembly of inflammasomes along the DNA structure. 68 This is in contrast with NLR-based inflammasome that can oligomerize independently of their ligand.
| Autoimmunity
In addition to its role in triggering inflammation, self-DNA is also as- 
| Cancer
Tumorigenesis and inflammation are known to be tightly interwined.
Chronic inflammation promoted by environment, microbial organisms, or microbiota is a major driver of cancer. 153 161 Reconstitution of HCC cell lines with AIM2 diminished their proliferation and invasiveness while further decreasing the expression of AIM2 augmented signs of disease. 160, 161 In this cancer type the AIM2 inflammasome was proposed to negatively impact the mTOR-S6K1 pathway. Reconstitution of AIM2 expression in HCC cell lines had an inhibitory effect on mTOR and S6K1 phosphorylation that was reversed by caspase-1 inhibition.
Reconstitution of AIM2 expression also impaired tumor growth in a HCC xenograft model. 160 In a different mouse model of HCC, decreased AIM2 expression led to increased number of liver tumors and lung nodules. 161 AIM2 silencing increased Fibronectin 1 (FN1), a factor that could be responsible for the epithelial to mesenchymal transition enabling HCC metastasis. 161 Whether AIM2 ability to repress FN1 depends on inflammasome assembly has not been investigated so far.
Recently, two studies characterized the role of AIM2 in a murine model of colitis-associated cancer chemically induced by azoxymethane (AOM) injection followed by dextran sodium sulfate (DSS) treatment. 162, 163 One study used the AOM/DSS model to demonstrate that AIM2 suppression of colon tumorigenesis was independent of inflammasome formation and instead relied on the suppression of the DNA-PK-Akt axis. 163 Additionally, the sporadic development of colon cancer in Apc Min/− model, was aggravated by AIM2 deficiency. Increased Akt phosphorylation in AIM2 deficient tumors correlated with bigger tumor load. It was proposed that AIM2 could directly interact with DNA-PK, an Akt kinase activated by DNA damage, possibly limiting DNA-PK activation and subsequent Akt phosphorylation and cell proliferation. 163 The second study showed that the inflammasome-independent role for AIM2 in the protection against colon cancer was mainly driven by stromal cell expression of AIM2 and not by myeloid cells. 162, 163 Consistently they observed that AIM2-deficiency increased proliferation in vivo and Akt phosphorylation. Colonic epithelial progenitor stem cells purified from AIM2 deficient mice were more prone to form larger organoids than control mice. Moreover, aberrant activation of the WNT/β-catenin pathway increased proliferation of epithelial stem cells in the colonic crypts of AIM2-deficient mice. 162 Conversely, AIM2 expression was increased in human cutaneous squamous cell carcinoma (cSCC). 164 Comparison of AIM2 expression levels between normal human epithelial keratinocytes and cSCC cell lines showed higher expression of AIM2 in cSCC cells. AIM2 expression correlated with the grade of the tumors, being low in normal skin, low to moderate in actinic keratosis (precancer) lesions, moderate to high in primary cSCC tumors and high in invasive cSCC tumors. This occurred both in sporadic cSCC and cSCC associated with organ transplant. 164 Pathway analysis of gene expression profiles after decreasing AIM2 in cSCC cell lines revealed alterations in pathways controlling cell cycle, proliferation and invasiveness. In vivo, decreasing AIM2 expression in human cSCC cells prior to xenograft transplantation in SCID mice promoted a reduction in tumor volume, cell proliferation, and tumor vascularization. 164 Of note, the implication of inflammasome assembly in this tumor type has not been investigated yet. Other cancers, associated with viral infections, such as EpsteinBarr virus 165 or human papillomavirus 166 also exhibited increased AIM2 expression. Altogether these studies demonstrate that AIM2
has a key role in regulating tumorigenesis, however, the mechanisms involved are poorly understood. Importantly it appears that at least some of AIM2 functions during tumorigenesis may not rely on the assembly of typical inflammasome platforms.
| CONCLUSIONS AND PERSPECTIVES
Inflammasomes are key players in the regulation of cellular stress and immune responses. The molecular mechanisms governing initiation and assembly of inflammasomes are still poorly understood.
While most inflammasomes described so far respond to wellcharacterized stimuli, how the signal is transmitted to the scaffolding receptor is mostly unknown. The ligands of most inflammasome complexes are still unclear or poorly characterized except for AIM2
that is a bona fide DNA detector. DNA is ubiquitous; therefore, AIM2 can be considered a sensor of pathogens when it detects microbial DNA. However, when it detects mislocalized self-DNA, it functions as a sensor of altered self. It behaves as a guardian of cellular integrity that can respond to perturbations and loss of cellular homeostasis such as, for example, disruption of nuclear envelope integrity. This raises several questions that remain to be elucidated.
Recent studies have demonstrated that AIM2 detects self-DNA.
However, how this detection is regulated to achieve specificity to detect pathogen and stress conditions and how this contributes to immune responses still remains unclear. During mitosis, the phosphorylation of nuclear lamins causes the nuclear envelope to disintegrate into small membrane vesicles. The disruption of the nuclear compartment exposes chromosomal DNA to cytosolic components.
Whether DNA packed within chromosomes can engage AIM2 is debated. However, it is likely that during mitosis dsDNA is exposed and mechanisms are in place to avoid aberrant AIM2 activation. This has been proposed for the NLRP3 inflammasome. NLRP3 activation requires the binding of NEK7, a kinase involved in cell cycle. It was hypothesized that NEK7 function and regulation during cell cycle, limits its availability to engage NLRP3, thereby dampening NLRP3 activation. 167 Thus, this mechanism limits NLRP3 activation during cell cycle and restricts it to cells in interphase. Why NLRP3 activation is blocked during cell cycle progression is currently unknown, and NEK7 does not affect AIM2 activation. However, it is tempting to speculate that similar mechanisms, yet to be described, may function as a safeguard to limit aberrant AIM2 activation in cells undergoing cell division.
The function of AIM2 is also highly controlled by regulation of its expression and subcellular localization that may vary depending on several factors including the activation of other DNA sensors, the overall inflammatory status, and the tissues involved.
Moreover the contribution of AIM2 regulators such as POP3, p202, and TRIM11 are still poorly understood and need to be evaluated in physiological models. 155 It would be important to understand the contribution of these regulators to the modulation of the intensity and duration of the response as well as their possible role as safeguard mechanisms limiting aberrant detection of self-DNA.
AIM2 has been mostly studied in cells of the immune system or in the context of infection and immune deregulation, however, its role in other tissues awaits dedicated studies. Evidences suggests, for example that, in neurons, AIM2 may contribute neuronal morphology and influence anxiety and memory in mice. 115 Another important question that is emerging is the contribution of AIM2 to inflammasome independent processes. This has been shown mostly in cancer cells, but may also contribute to some of the phenotype observed in AIM2 deficient mice.
It is foreseeable that these questions will uncover new functions of AIM2 and provide a better understanding of the mechanisms by which it promotes immunity and contributes to diseases, in particular those with signs of autoinflammation and autoimmunity.
